drugset / Trial / NCT00135525
Study Of Generalized Anxiety Disorder
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is designed to evaluate the efficacy and safety in Generalized Anxiety Disorder patients
Timeline
- Start
- 2003-05
- Primary completion
- 2005-10
- Completion
- 2006-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paroxetine | Small molecule | 20 mg | Oral |
| Subject | Paroxetine | Small molecule | 30 mg | Oral |
| Subject | Paroxetine | Small molecule | 40 mg | Oral |